Modular Phage Library Construction for High-Diversity Antibody Display
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing phage libraries face challenges such as small library capacity, insufficient diversity, high cost, long construction time, quality control difficulties, and poor stability during storage, making them unsuitable for industrial mass production.
Innovation Solution
A method involving controlled PCR amplification, specific restriction endonuclease sites for directed connections, and bacterial libraries for constructing phage libraries with improved conversion efficiency, allowing for large capacity and diversity, enabling quality control at each step, and long-term storage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional overlapping PCR strategy is used to construct phage library, then library construction can be completed, but PCR mutations are introduced and library capacity remains limited
Solution Approach 1:
The patent divides the antibody gene construction into separate modules (heavy chain variable region, light chain variable region, and constant regions) that are amplified independently through PCR and then assembled using restriction endonuclease sites. This segmentation allows each component to be optimized separately, reducing cumulative PCR mutations while maintaining construction efficiency.
Solution Approach 2:
The patent introduces restriction endonuclease recognition sites into the PCR primers during the initial amplification step. This preliminary action enables subsequent directional cloning without requiring additional PCR steps, thereby reducing the number of PCR cycles and minimizing mutation accumulation while streamlining the construction process.
2Quantity of substance
If multiple smaller libraries are accumulated to expand capacity, then library size increases, but construction time extends to several years and quality consistency cannot be ensured
Solution Approach 1:
The patent segments the phage library construction into independent bacterial library components (heavy chain library, light chain library) that can be constructed separately and then combined. This allows parallel construction of multiple components simultaneously rather than sequential accumulation, dramatically reducing total construction time while achieving large overall library capacity.
Solution Approach 2:
The patent performs preliminary construction and validation of individual bacterial libraries containing antibody gene segments before combining them into the final phage library. This preliminary action ensures each component meets quality standards independently, guaranteeing consistency when libraries are combined to achieve large capacity without requiring years of sequential construction.
3Ease of manufacture
If library construction is performed without intermediate quality control, then process is simpler, but quality cannot be known until library establishment resulting in high failure risk
Solution Approach 1:
The patent divides quality control into discrete checkpoints at each modular stage (PCR amplification of individual gene segments, cloning into bacterial vectors, bacterial library validation) before final phage library assembly. This segmented approach maintains relative process simplicity while enabling systematic quality verification at each step, reducing overall failure risk.
Solution Approach 2:
The patent implements feedback mechanisms at each construction stage by validating bacterial libraries for proper gene insertion and expression before proceeding to phage library construction. This feedback ensures quality issues are detected and corrected early in the process, maintaining reliability without significantly complicating the overall manufacturing workflow.
4Productivity
If existing methods are used for library construction, then initial library can be produced, but cost is high, period is long, and quality declines after long-term storage making industrial mass production difficult
Solution Approach 1:
The patent segments the antibody library into stable bacterial library components that can be constructed and validated separately, then combined to form the final phage library. The bacterial libraries serve as stable stock materials that can be stored and quality-tested before production, enabling industrial-scale operations with consistent quality assurance and reduced storage-related degradation.
Solution Approach 2:
The patent performs preliminary construction and comprehensive quality validation of bacterial libraries containing antibody gene segments before combining them into the final phage library intended for industrial production. This preliminary action ensures optimal stability and quality are established before long-term storage and mass production, preventing quality decline during storage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces a phage library with high specificity and efficiency, facilitating rapid selection of antibodies or fragments, meeting industrial demands with ease of operation and quality assurance.
Implementation Method 1
The light chain and the heavy chain and the connexon are amplified by PCR only once each
Implementation Method 2
the phage library of the present application can be constructed with the recognition site(s) of specific restriction endonuclease, which can both ensure directed connection, and prevent mis-connection
Implementation Method 3
connected to desired components to obtain the phage library of Fab
Data Source
AI summary
Provided is method for producing a phage library displaying antibodies or antibody fragments, comprising providing a first polynucleotide containing LC, a second polynucleotide containing connexon, and a third polynucleotide containing HC, respectively introducing the first, second and third polynucleotides to first, second and third bacteria to obtain a light chain component bacterial library, a connexon component bacterial library, and a heavy chain component bacterial library, obtaining a light chain component plasmid, a connexon component plasmid, and a heavy chain component plasmid from the libraries, obtaining the released LC, released connexon and released HC from the plasmids, connecting the released display vector segments to form a connection product for display, introducing a third bacterium to obtain a display bacterial library, and using the display bacterial library to prepare the phage library for displaying the antibodies or antibody fragments. Also provided is a phage library produced according to the method.